Retina/Vitreous

Top Story

Pr3vent closes Series A funding round for AI development

February 18, 2019

Regeneron presents positive data from PANORAMA trial

February 14, 2019
Patients in the PANORAMA trial who underwent early intervention with Eylea experienced improvements in diabetic retinopathy severity, and the majority experienced…

Ocugen gene therapy receives orphan drug designation

February 14, 2019
The FDA has granted orphan drug designation to OCU400, Ocugen’s gene therapy for the treatment of NR2E3 mutation-associated retinal degenerative disease…

Spectralis with OCT2 module installed at International Space Station

February 14, 2019
A Spectralis imaging platform with OCT2 module has been installed at the International Space Station, where it will be used to study space flight associated neuro-ocular…
More Headlines »
Clinical Science

Revisiting Autologous Platelets as an Adjuvant in Macular Hole Repair: Chronic Macular Holes Without Prone Positioning

Ophthalmic Surgery, Lasers and Imaging Retina, July 2012, Volume 43 Issue 4
Chronic macular hole and inability to maintain prone positioning remain poor prognostic markers for successful macular…
More »
CME

Long-term Management of Neovascular AMD: Meeting the Need for Improvement

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Age-related macular degeneration (AMD) is a leading cause of irreversible blindness and visual impairment. As…
More »
Video
Meeting News

VIDEO: Exciting therapies in development for treating DME

January 22, 2019
More »

Pr3vent closes Series A funding round for AI development

February 18, 2019
Pr3vent, which is developing artificial intelligence for early detection of preventable vision loss in healthy term newborn infants, closed a round…

Regeneron presents positive data from PANORAMA trial

February 14, 2019
Patients in the PANORAMA trial who underwent early intervention with Eylea experienced improvements in diabetic retinopathy severity, and the…

Ocugen gene therapy receives orphan drug designation

February 14, 2019
The FDA has granted orphan drug designation to OCU400, Ocugen’s gene therapy for the treatment of NR2E3 mutation-associated retinal…

Spectralis with OCT2 module installed at International Space Station

February 14, 2019
A Spectralis imaging platform with OCT2 module has been installed at the International Space Station, where it will be used to study space flight…

Grand Rounds at the New England Eye Center

Woman presents with unilateral blurry vision

Ocular Surgery News U.S. Edition, February 25, 2019
Malgorzata Dymerska, MD; Shilpa J. Desai, MD
A 72-year-old woman was referred to the New England Eye Center for evaluation of 1 to 2 months of progressive blurry vision in the right eye. The…

Researchers link genes to AMD

February 13, 2019
Scientists have identified several new associations between genes and age-related macular degeneration, providing “a more in-depth picture of…

Meeting NewsVideo

VIDEO: Diagnosis, management of ROP an evolving field

February 7, 2019
WAIKOLOA, Hawaii — At Retina 2019, R.V. Paul Chan, MD, updates his colleagues on the diagnosis and management of retinopathy of prematurity, a…

Janssen, MeiraGTx to develop gene therapy programs

February 6, 2019
Janssen Pharmaceutical Companies announced a worldwide collaboration and license agreement with MeiraGTx Holdings to develop, manufacture and…

Meeting NewsVideo

VIDEO: Retina World Congress revives the ARVO Fort Lauderdale feeling

February 5, 2019
WAIKOLOA, Hawaii — Rishi P. Singh, MD, discusses the upcoming Retina World Congress to be held…

EyePoint launches Yutiq in US

February 4, 2019
EyePoint Pharmaceuticals announced the commercial launch of Yutiq, an intravitreal implant containing fluocinolone acetonide, in the United States. …

What to look forward to at Retina World Congress

February 1, 2019
The second Retina World Congress will take place in Fort Lauderdale, Florida, March 21 to 24, bringing retina specialists from across the globe…

Meeting NewsVideo

VIDEO: Visual acuity unchanged after macular hole closure in patients with wet AMD

February 1, 2019
WAIKOLOA, Hawaii — There was no statistically significant difference in visual acuity results in patients with wet age-related macular…

Aldeyra acquires Helio Vision

January 31, 2019
Aldeyra Therapeutics has acquired the biotechnology company Helio Vision, according to a press release. The acquisition adds Helio’s ADX-2191…

Meeting News

Inflammation control key to surgical success for treating uveitis

January 28, 2019
WAIKOLOA, Hawaii — In eyes with uveitis scheduled for surgery, inflammation control preoperatively and postoperatively is key to success, a…

Meeting NewsVideo

VIDEO: Aerie updates its glaucoma and retina pipeline

January 28, 2019
WAIKOLOA, Hawaii — Tom Mitro, president and chief operating officer of Aerie Pharmaceuticals, discusses the company’s product…

In the Journals PlusPerspective

HIV, syphilis coinfection increases risk for ocular syphilis

January 27, 2019
Patients coinfected with HIV and syphilis are nearly twice as likely to experience symptoms of ocular syphilis compared with patients without HIV…

Meeting NewsVideo

VIDEO: EyePoint to launch two new products in first quarter

January 27, 2019
WAIKOLOA, Hawaii — Nancy Lurker, CEO of EyePoint Pharmaceuticals, discusses the planned launch of Yutiq (fluocinolone acetonide intravitreal…

Meeting News

Scleral buckling or vitrectomy for primary retinal detachment up to surgeon preference

January 25, 2019
WAIKOLOA, Hawaii — Whether to perform scleral buckle alone or add it to pars plana vitrectomy in cases of primary rhegmatogenous retinal…

Meeting News

Total dose of hydroxychloroquine plays role in ocular toxicity

January 24, 2019
WAIKOLOA, Hawaii — Hydroxychloroquine is used extensively by rheumatologists and dermatologists and yields little systemic concerns, but…

Meeting News

Speaker shares lessons learned after testifying in pediatric trauma case

January 24, 2019
WAIKOLOA, Hawaii — In lessons learned from a day in court, Robin A. Vora, MD, shared his insights into being called to testify in a pediatric…

More Headlines »